Tango Therapeutics Analyst Ratings
Tango Therapeutics Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/08/2023 | 219.77% | HC Wainwright & Co. | → $11 | Reiterates | Buy → Buy |
| 05/10/2023 | 423.26% | Wedbush | → $18 | Reiterates | → Outperform |
| 03/28/2023 | 219.77% | HC Wainwright & Co. | $10 → $11 | Maintains | Buy |
| 10/20/2022 | 190.7% | HC Wainwright & Co. | → $10 | Initiates Coverage On | → Buy |
| 09/20/2021 | 626.74% | SVB Leerink | → $25 | Initiates Coverage On | → Outperform |
| 09/07/2021 | 365.12% | Guggenheim | → $16 | Initiates Coverage On | → Buy |
| 09/07/2021 | 481.4% | Wedbush | → $20 | Initiates Coverage On | → Outperform |
| 09/07/2021 | 394.19% | Goldman Sachs | → $17 | Initiates Coverage On | → Buy |
| 日期 | 上行/下行 | 分析公司 | 目標價格變動 | 評級變動 | 之前/當前的評級 |
|---|---|---|---|---|---|
| 08/08/2023 | 219.77% | HC Wainwright & Co. | → 11 美元 | 重申 | 購買 → 購買 |
| 05/10/2023 | 423.26% | Wedbush | → 18 美元 | 重申 | → 跑贏大盤 |
| 03/28/2023 | 219.77% | HC Wainwright & Co. | 10 美元 → 11 美元 | 維護 | 購買 |
| 2022 年 10 月 20 日 | 190.7% | HC Wainwright & Co. | → 10 美元 | 啓動覆蓋開啓 | → 購買 |
| 09/20/2021 | 626.74% | SVB Leerink | → 25 美元 | 啓動覆蓋開啓 | → 跑贏大盤 |
| 09/07/2021 | 365.12% | 古根海姆 | → 16 美元 | 啓動覆蓋開啓 | → 購買 |
| 09/07/2021 | 481.4% | Wedbush | → 20 美元 | 啓動覆蓋開啓 | → 跑贏大盤 |
| 09/07/2021 | 394.19% | 高盛 | → 17 美元 | 啓動覆蓋開啓 | → 購買 |
What is the target price for Tango Therapeutics (TNGX)?
Tango Therapeutics（TNGX）的目標價格是多少？
The latest price target for Tango Therapeutics (NASDAQ: TNGX) was reported by HC Wainwright & Co. on August 8, 2023. The analyst firm set a price target for $11.00 expecting TNGX to rise to within 12 months (a possible 219.77% upside). 4 analyst firms have reported ratings in the last year.
HC Wainwright & Co. 於2023年8月8日公佈了Tango Therapeutics（納斯達克股票代碼：TNGX）的最新目標股價。這家分析公司將目標股價定爲11.00美元，預計TNGX將在12個月內升至12個月內（可能上漲219.77％）。去年有4家分析公司公佈了評級。
What is the most recent analyst rating for Tango Therapeutics (TNGX)?
分析師對Tango Therapeutics（TNGX）的最新評級是多少？
The latest analyst rating for Tango Therapeutics (NASDAQ: TNGX) was provided by HC Wainwright & Co., and Tango Therapeutics reiterated their buy rating.
Tango Therapeutics（納斯達克股票代碼：TNGX）的最新分析師評級由HC Wainwright & Co. 提供，Tango Therapeutics重申了他們的買入評級。
When is the next analyst rating going to be posted or updated for Tango Therapeutics (TNGX)?
Tango Therapeutics（TNGX）的下一個分析師評級何時公佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Tango Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Tango Therapeutics was filed on August 8, 2023 so you should expect the next rating to be made available sometime around August 8, 2024.
分析師在進行了廣泛的研究後得出了股票評級，其中包括瀏覽公開財務報表，與Tango Therapeutics的高管和客戶交談，以及聽取業績電話會議。大多數分析師每三個月進行一次評級，因此每家公司每年應該獲得4個評級。Tango Therapeutics的最後一次評級是在2023年8月8日提交的，因此你應該預計下一個評級將在2024年8月8日左右公佈。
Is the Analyst Rating Tango Therapeutics (TNGX) correct?
分析師對 Tango Therapeutics (TNGX) 的評級正確嗎？
While ratings are subjective and will change, the latest Tango Therapeutics (TNGX) rating was a reiterated with a price target of $0.00 to $11.00. The current price Tango Therapeutics (TNGX) is trading at is $3.44, which is within the analyst's predicted range.
儘管評級是主觀的，將會發生變化，但最新的Tango Therapeutics（TNGX）評級得到了重申，目標股價爲0.00美元至11.00美元。Tango Therapeutics（TNGX）目前的交易價格爲3.44美元，在分析師的預測區間內。